Matches in SemOpenAlex for { <https://semopenalex.org/work/W2416176422> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2416176422 endingPage "84" @default.
- W2416176422 startingPage "579" @default.
- W2416176422 abstract "Docetaxel (TXT) has been shown to be an up-regulator of human pyrimidine nucleoside phosphorylase (PyNPase) in tumors. We have tried to use the combination of low-dose weekly TXT with 5'-DFUR (LD + D) in patients with advanced or metastatic breast cancer. In this study, we compared the clinical efficacy of LD + D with that of conventional full-dose TXT (FD) and that of low-dose weekly TXT (LD). Twenty-one patients received 3 or 4 cycles of FD 60 mg/m2 every 3 or 4 weeks (group I), 14 patients received 8 cycles of LD 20-30 mg/m2 every week (group II) and 25 patients received 8 cycles of LD 20-30 mg/m2 weekly with oral 5'-DFUR 600-1,200 mg per day (group III). The overall response rates of groups I, II and III were 29%, 29% and 52% (p = 0.24), respectively. Grade 3-4 neutropenia was observed in 91% of group I, 6% of group II and 3% of group III. Nausea was present in 27% of group I, 28% of group II and 40% of group III. Higher incidence of gastrointestinal symptoms was found in LD + D, but the symptoms abated when the doses of 5'-DFUR were reduced. Low-dose weekly TXT with oral 5'-DFUR produced a higher response rate, but less hematologic toxicity than full-dose TXT, suggesting that this combination therapy is clinically useful and may be effective for patients with advanced or metastatic breast cancer." @default.
- W2416176422 created "2016-06-24" @default.
- W2416176422 creator A5017878728 @default.
- W2416176422 creator A5044931539 @default.
- W2416176422 creator A5049837939 @default.
- W2416176422 creator A5053497711 @default.
- W2416176422 creator A5054301688 @default.
- W2416176422 creator A5058903427 @default.
- W2416176422 creator A5062706362 @default.
- W2416176422 creator A5083840962 @default.
- W2416176422 creator A5091351923 @default.
- W2416176422 date "2000-04-01" @default.
- W2416176422 modified "2023-09-23" @default.
- W2416176422 title "[Clinical efficacy of low-dose weekly docetaxel combined with oral 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced or metastatic breast cancer: a pilot trial]." @default.
- W2416176422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10791000" @default.
- W2416176422 hasPublicationYear "2000" @default.
- W2416176422 type Work @default.
- W2416176422 sameAs 2416176422 @default.
- W2416176422 citedByCount "0" @default.
- W2416176422 crossrefType "journal-article" @default.
- W2416176422 hasAuthorship W2416176422A5017878728 @default.
- W2416176422 hasAuthorship W2416176422A5044931539 @default.
- W2416176422 hasAuthorship W2416176422A5049837939 @default.
- W2416176422 hasAuthorship W2416176422A5053497711 @default.
- W2416176422 hasAuthorship W2416176422A5054301688 @default.
- W2416176422 hasAuthorship W2416176422A5058903427 @default.
- W2416176422 hasAuthorship W2416176422A5062706362 @default.
- W2416176422 hasAuthorship W2416176422A5083840962 @default.
- W2416176422 hasAuthorship W2416176422A5091351923 @default.
- W2416176422 hasConcept C121608353 @default.
- W2416176422 hasConcept C126322002 @default.
- W2416176422 hasConcept C143998085 @default.
- W2416176422 hasConcept C2775930923 @default.
- W2416176422 hasConcept C2777063308 @default.
- W2416176422 hasConcept C2780580376 @default.
- W2416176422 hasConcept C2781190966 @default.
- W2416176422 hasConcept C29730261 @default.
- W2416176422 hasConcept C530470458 @default.
- W2416176422 hasConcept C71924100 @default.
- W2416176422 hasConcept C90924648 @default.
- W2416176422 hasConceptScore W2416176422C121608353 @default.
- W2416176422 hasConceptScore W2416176422C126322002 @default.
- W2416176422 hasConceptScore W2416176422C143998085 @default.
- W2416176422 hasConceptScore W2416176422C2775930923 @default.
- W2416176422 hasConceptScore W2416176422C2777063308 @default.
- W2416176422 hasConceptScore W2416176422C2780580376 @default.
- W2416176422 hasConceptScore W2416176422C2781190966 @default.
- W2416176422 hasConceptScore W2416176422C29730261 @default.
- W2416176422 hasConceptScore W2416176422C530470458 @default.
- W2416176422 hasConceptScore W2416176422C71924100 @default.
- W2416176422 hasConceptScore W2416176422C90924648 @default.
- W2416176422 hasIssue "4" @default.
- W2416176422 hasLocation W24161764221 @default.
- W2416176422 hasOpenAccess W2416176422 @default.
- W2416176422 hasPrimaryLocation W24161764221 @default.
- W2416176422 hasRelatedWork W2016786152 @default.
- W2416176422 hasRelatedWork W2051530062 @default.
- W2416176422 hasRelatedWork W2086399528 @default.
- W2416176422 hasRelatedWork W2103792825 @default.
- W2416176422 hasRelatedWork W2327409371 @default.
- W2416176422 hasRelatedWork W2343175228 @default.
- W2416176422 hasRelatedWork W2361778159 @default.
- W2416176422 hasRelatedWork W2387550907 @default.
- W2416176422 hasRelatedWork W2414026566 @default.
- W2416176422 hasRelatedWork W3007224384 @default.
- W2416176422 hasVolume "27" @default.
- W2416176422 isParatext "false" @default.
- W2416176422 isRetracted "false" @default.
- W2416176422 magId "2416176422" @default.
- W2416176422 workType "article" @default.